C4 therapeutics to participate in the stifel 2024 targeted oncology forum

Watertown, mass., april 09, 2024 (globe newswire) -- c4 therapeutics, inc. (c4t) (nasdaq: cccc), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that c4t management will participate in a fireside chat at the stifel 2024 targeted oncology forum taking place virtually from april 16 – april 17, 2024.

CCCC Ratings Summary

CCCC Quant Ranking